A 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Jan 13

PMID 33435170

Citations 31

Authors

Eileen Reidy

Niamh A Leonard

Oliver Treacy

Aideen E Ryan

Affiliations

Soon will be listed here.

Abstract

Although there have been many advances in recent years for the treatment of colorectal cancer (CRC), it still remains the third most common cause of cancer-related deaths worldwide. Many patients with late stage CRC display resistance to multiple different therapeutics. An important aspect in developing effective therapeutics for CRC patients is understanding the interactions that take place in the tumor microenvironment (TME), as it has been shown to contribute to drug resistance in vivo. Much research over the past 100 years has focused on 2D monolayer cultures or in vivo studies, however, the efficacy in translating these to the clinic is very low. More recent studies are turning towards developing an effective 3D model of CRC that is clinically relevant, that can recapitulate the TME in vitro and bridge the gap between 2D cultures and in vivo studies, with the aim of reducing the use of animal models in the future. This review summarises the advantages and limitations of different 3D CRC models. It emphasizes how different 3D models may be optimised to study cellular and extracellular interactions that take place in the TME of CRC in an effort to allow the development of more translatable effective treatment options for patients.

Citing Articles

Three-dimensional models: from cell culture to Patient-Derived Organoid and its application to future liposarcoma research.

Tahara S, Rentsch S, DE Faria F, Sarchet P, Karna R, Calore F Oncol Res. 2024; 33(1):1-13.

PMID: 39735679 PMC: 11671414. DOI: 10.32604/or.2024.053635.

Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma.

Feely S, Mullen N, Donlon P, Reidy E, Challapalli R, Hassany M Endocrinology. 2024; 166(1).

PMID: 39656817 PMC: 11650001. DOI: 10.1210/endocr/bqae159.

Establishment and drug resistance characterization of paired organoids using human primary colorectal cancer and matched tumor deposit specimens.

Deng J, Qin J, Li X, Tao D, Feng Y Hum Cell. 2024; 38(1):13.

PMID: 39495391 PMC: 11534897. DOI: 10.1007/s13577-024-01139-x.

Biomedical applications of stimuli-responsive "smart" interpenetrating polymer network hydrogels.

Wu J, Xue W, Yun Z, Liu Q, Sun X Mater Today Bio. 2024; 25:100998.

PMID: 38390342 PMC: 10882133. DOI: 10.1016/j.mtbio.2024.100998.

Delivery and Transcriptome Assessment of an In Vitro Three-Dimensional Proximal Tubule Model Established by Human Kidney 2 Cells in Clinical Gelatin Sponges.

Hsiao H, Yen T, Wu F, Cheng C, Liu J, Fan Y Int J Mol Sci. 2023; 24(21).

PMID: 37958530 PMC: 10650118. DOI: 10.3390/ijms242115547.

References

Sensi F, DAngelo E, DAronco S, Molinaro R, Agostini M . Preclinical three-dimensional colorectal cancer model: The next generation of in vitro drug efficacy evaluation. J Cell Physiol. 2018; 234(1):181-191. DOI: 10.1002/jcp.26812. View

Arina A, Idel C, Hyjek E, Alegre M, Wang Y, Bindokas V . Tumor-associated fibroblasts predominantly come from local and not circulating precursors. Proc Natl Acad Sci U S A. 2016; 113(27):7551-6. PMC: 4941507. DOI: 10.1073/pnas.1600363113. View

Barcellos-Hoff M, Aggeler J, Ram T, Bissell M . Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989; 105(2):223-35. PMC: 2948482. DOI: 10.1242/dev.105.2.223. View

Smit T, Calitz C, Willers C, Svitina H, Hamman J, Fey S . Characterization of an Alginate Encapsulated LS180 Spheroid Model for Anti-colorectal Cancer Compound Screening. ACS Med Chem Lett. 2020; 11(5):1014-1021. PMC: 7236536. DOI: 10.1021/acsmedchemlett.0c00076. View

Frezza E, Wachtel M, Chiriva-Internati M . Influence of obesity on the risk of developing colon cancer. Gut. 2005; 55(2):285-91. PMC: 1856517. DOI: 10.1136/gut.2005.073163. View

Carvalho M, Barata D, Teixeira L, Giselbrecht S, Reis R, Oliveira J . Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine. Sci Adv. 2019; 5(5):eaaw1317. PMC: 6531003. DOI: 10.1126/sciadv.aaw1317. View

Wang J, Douville N, Takayama S, Elsayed M . Quantitative analysis of molecular absorption into PDMS microfluidic channels. Ann Biomed Eng. 2012; 40(9):1862-73. DOI: 10.1007/s10439-012-0562-z. View

Zhao X, Qu J, Sun Y, Wang J, Liu X, Wang F . Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature. Oncotarget. 2017; 8(18):30576-30586. PMC: 5444766. DOI: 10.18632/oncotarget.15736. View

Greten F, Eckmann L, Greten T, Park J, Li Z, Egan L . IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004; 118(3):285-96. DOI: 10.1016/j.cell.2004.07.013. View

10.

Ryan A, Colleran A, OGorman A, OFlynn L, Pindjacova J, Lohan P . Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis. Oncogene. 2014; 34(12):1563-74. DOI: 10.1038/onc.2014.86. View

11.

Ma Y, Yang W, Song M, Smith-Warner S, Yang J, Li Y . Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts. Br J Cancer. 2018; 119(11):1436-1442. PMC: 6265303. DOI: 10.1038/s41416-018-0314-4. View

12.

Hsiao C, Huang W, Ke T, Muo C, Chen W, Sung F . Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study. Eur J Intern Med. 2013; 25(1):82-6. DOI: 10.1016/j.ejim.2013.11.005. View

13.

Lin J, Wang J, Chen M, Chen H, Chang T, Su B . Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Exp Cell Res. 2013; 319(14):2216-29. DOI: 10.1016/j.yexcr.2013.06.003. View

14.

Miyoshi H, Maekawa H, Kakizaki F, Yamaura T, Kawada K, Sakai Y . An improved method for culturing patient-derived colorectal cancer spheroids. Oncotarget. 2018; 9(31):21950-21964. PMC: 5955161. DOI: 10.18632/oncotarget.25134. View

15.

Chen S, Nakamoto T, Kawazoe N, Chen G . Engineering multi-layered skeletal muscle tissue by using 3D microgrooved collagen scaffolds. Biomaterials. 2015; 73:23-31. DOI: 10.1016/j.biomaterials.2015.09.010. View

16.

Mori R, Yoshida K, Futamura M, Suetsugu T, Shizu K, Tanahashi T . The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells. Gastric Cancer. 2018; 22(3):497-505. PMC: 6476841. DOI: 10.1007/s10120-018-0881-3. View

17.

Hamburger A, Salmon S . Primary bioassay of human tumor stem cells. Science. 1977; 197(4302):461-3. DOI: 10.1126/science.560061. View

18.

Schrader J, Gordon-Walker T, Aucott R, van Deemter M, Quaas A, Walsh S . Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology. 2011; 53(4):1192-205. PMC: 3076070. DOI: 10.1002/hep.24108. View

19.

Zhang R, Qi F, Shao S, Li G, Feng Y . Human colorectal cancer-derived carcinoma associated fibroblasts promote CD44-mediated adhesion of colorectal cancer cells to endothelial cells by secretion of HGF. Cancer Cell Int. 2019; 19:192. PMC: 6657169. DOI: 10.1186/s12935-019-0914-y. View

20.

Longley D, Johnston P . Molecular mechanisms of drug resistance. J Pathol. 2005; 205(2):275-92. DOI: 10.1002/path.1706. View